92
Views
23
CrossRef citations to date
0
Altmetric
Review

Therapeutic options in mantle cell lymphoma

&
Pages 398-409 | Received 21 Oct 2007, Accepted 06 Dec 2007, Published online: 01 Jul 2009
 

Abstract

Mantle cell lymphoma (MCL) is an aggressive lymphoma requiring intensive chemotherapy ± autologous stem cell transplantation (SCT) to achieve optimal rates of progression-free survival. Here we review the treatment options for patients with newly-diagnosed or relapsed MCL and discuss recent advances in management, including the role of autologous and allogeneic SCT.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.